MM
MICHAEL MCCARTY
MICHAEL N. MCCARTY LAW OFFICE PLLC · Washington, DC · registered since 2024
Registered · LDAActive
At a glance
Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
2 agencies contacted
Activity
filings by quarter
Works on
Specific issues
Legislation to regulate laboratory-developed in vitro diagnostic (IVD) tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to the Medical Laboratory Personnel Shortage Relief Act of 2024 (H.R.9849); support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014; support Improving Seniors' Timely Access to Care Act of 2024 (H.R. 8702 / S. 4532).
Support funding for the Centers for Disease Control (CDC) Environmental Health Laboratory to "harmonize" clinical diagnostic test results and to establish pediatric reference intervals for in vitro diagnostic (IVD) tests performed on children; support enhanced funding for CDC's Advanced Molecular Detection program; monitor legislation to regulate laboratory-developed IVD tests, including the Verifying Accurate Leading-edge IVCT Development (VALID) Act (H.R. 2369); support clinical laboratory and allied health workforce enhancement initiatives, including but not limited to expansion of health workforce programs administered by the Health Resource and Services Administration, funding for the Public Health Workforce Loan Repayment Program and the Bio-Preparedness Workforce Pilot Program; support the Freedom to Invest in Tomorrow's Workforce Act (S. 722/H.R. 1477).
Support enactment of the Saving Access to Laboratory Services Act (S. 1000 / H.R. 2377); support delay in implementation of Medicare Clinical Laboratory Fee Schedule payment reductions and data reporting requirements under Sec. 216 of the Protecting Access to Medicare Act of 2014.